Srs Capital Advisors, Inc. Bristol Myers Squibb CO Transaction History

Srs Capital Advisors, Inc.

$1.07 Billion
Q3 2024

A detailed history of Srs Capital Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 4,247 shares of BMY stock, worth $246,326. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,247

Previous 3,891 9.15%

Holding current value

$246,326

Previous $161,000 36.02%

% of portfolio

0.02%

Previous 0.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$39.66 - $51.75 $14,118 - $18,423	356 Added 9.15%	4,247 $219,000
Q2 2024 Aug 06, 2024	BUY	$40.25 - $52.99 $117,127 - $154,200	2,910 Added 296.64%	3,891 $161,000
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $5,709 - $6,473	119 Added 13.81%	981 $53,000
Q4 2023 Feb 06, 2024	SELL	$48.48 - $57.85 $2,133 - $2,545	-44 Reduced 4.86%	862 $44,000
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $6,831 - $7,638	-118 Reduced 11.52%	906 $52,000
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $32,810 - $36,431	-515 Reduced 33.46%	1,024 $65,000
Q1 2023 May 16, 2023	SELL	$65.71 - $74.53 $919 - $1,043	-14 Reduced 0.9%	1,539 $106,000
Q4 2022 Feb 24, 2023	BUY	$68.48 - $81.09 $616 - $729	9 Added 0.58%	1,553 $111,000
Q3 2022 Nov 03, 2022	SELL	$0.13 - $76.84 $86 - $51,175	-666 Reduced 30.14%	1,544 $110,000
Q2 2022 Aug 22, 2022	BUY	$72.62 - $79.98 $4,357 - $4,798	60 Added 2.79%	2,210 $170,000
Q1 2022 May 12, 2022	SELL	$61.48 - $73.72 $159,233 - $190,934	-2,590 Reduced 54.64%	2,150 $157,000
Q4 2021 Feb 08, 2022	SELL	$53.63 - $62.52 $8,366 - $9,753	-156 Reduced 3.19%	4,740 $296,000
Q3 2021 Nov 05, 2021	BUY	$59.17 - $69.31 $13,609 - $15,941	230 Added 4.93%	4,896 $290,000
Q2 2021 Aug 02, 2021	BUY	$61.91 - $67.42 $54,480 - $59,329	880 Added 23.24%	4,666 $312,000
Q4 2020 Feb 03, 2021	BUY	$57.74 - $65.43 $15,878 - $17,993	275 Added 7.83%	3,786 $235,000
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $151,500 - $167,882	-2,638 Reduced 42.9%	3,511 $212,000
Q2 2020 Aug 06, 2020	BUY	$54.82 - $64.09 $20,612 - $24,097	376 Added 6.51%	6,149 $362,000
Q1 2020 May 13, 2020	BUY	$46.4 - $67.43 $788 - $1,146	17 Added 0.3%	5,773 $322,000
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $6,102 - $7,959	124 Added 2.2%	5,756 $369,000
Q2 2019 Aug 08, 2019	BUY	$44.62 - $49.34 $26,861 - $29,702	602 Added 11.97%	5,632 $255,000
Q4 2018 Feb 06, 2019	BUY	$48.76 - $63.23 $133,553 - $173,186	2,739 Added 119.55%	5,030 $261,000
Q3 2018 Nov 06, 2018	BUY	$55.19 - $62.25 $37,032 - $41,769	671 Added 41.42%	2,291 $142,000
Q2 2018 Aug 21, 2018	SELL	$50.53 - $62.98 $6,619 - $8,250	-131 Reduced 7.48%	1,620 $89,000
Q1 2018 May 14, 2018	BUY	$59.92 - $68.98 $14,860 - $17,107	248 Added 16.5%	1,751 $110,000
Q4 2017 Feb 15, 2018	BUY	$59.94 - $65.35 $539 - $588	9 Added 0.6%	1,503 $92,000
Q3 2017 Nov 15, 2017	BUY	$55.23 - $63.74 $82,513 - $95,227	1,494	1,494 $95,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.

Account

Srs Capital Advisors, Inc. Bristol Myers Squibb CO Transaction History